The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi.

The causative agent of Lyme borreliosis, the spirochete Borrelia burgdorferi, has been shown to induce expression of the urokinase receptor (uPAR); however, the role of uPAR in the immune response against Borrelia has never been investigated. uPAR not only acts as a proteinase receptor, but can also...

Full description

Bibliographic Details
Main Authors:	Joppe W R Hovius, Maarten F Bijlsma, Gerritje J W van der Windt, W Joost Wiersinga, Bastiaan J D Boukens, Jeroen Coumou, Anneke Oei, Regina de Beer, Alex F de Vos, Cornelis van 't Veer, Alje P van Dam, Penghua Wang, Erol Fikrig, Marcel M Levi, Joris J T H Roelofs, Tom van der Poll
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2009-05-01
Series:	PLoS Pathogens
Online Access:	http://europepmc.org/articles/PMC2678258?pdf=render

Similar Items

A tick gut protein with fibronectin III domains aids Borrelia burgdorferi congregation to the gut during transmission.
by: Sukanya Narasimhan, et al.
Published: (2014-08-01)

Urokinase receptor is necessary for bacterial defense against pneumonia-derived septic melioidosis by facilitating phagocytosis.
by: Wiersinga, W, et al.
Published: (2010)

Borrelia burgdorferi Induces TLR2-Mediated Migration of Activated Dendritic Cells in an Ex Vivo Human Skin Model.
by: Lauren M K Mason, et al.
Published: (2016-01-01)

Modulation of the tick gut milieu by a secreted tick protein favors Borrelia burgdorferi colonization
by: Sukanya Narasimhan, et al.
Published: (2017-08-01)

Tick-Tattoo: DNA Vaccination Against B. burgdorferi or Ixodes scapularis Tick Proteins
by: Michelle J. Klouwens, et al.
Published: (2021-02-01)

Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer
by: Efrat T. Harel, et al.
Published: (2019-11-01)

Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR
by: Bernard Degryse, et al.
Published: (2017-12-01)

Urokinase Receptor uPAR Downregulation in Neuroblastoma Leads to Dormancy, Chemoresistance and Metastasis
by: Anna A. Shmakova, et al.
Published: (2022-02-01)

Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer
by: Bing-Tao Zhai, et al.
Published: (2022-03-01)

Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display.
by: Tim J Schuijt, et al.
Published: (2011-01-01)

A doxycycline-inducible urokinase receptor (uPAR) upregulates uPAR activities including resistance to anoikis in human prostate cancer cell lines
by: Reiser Jakob, et al.
Published: (2007-05-01)

The relapsing fever spirochete Borrelia miyamotoi is cultivable in a modified Kelly-Pettenkofer medium, and is resistant to human complement
by: Alex Wagemakers, et al.
Published: (2014-09-01)

The Urokinase Receptor (uPAR) as a “Trojan Horse” in Targeted Cancer Therapy: Challenges and Opportunities
by: Virginia Metrangolo, et al.
Published: (2021-10-01)

E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
by: Shailza Sharma, et al.
Published: (2021-12-01)

Preliminary assessment of the possibility of using urokinase uPA and urokinase receptor uPAR as universal diagnostic criteria in patients with colorectal and gastric adenocarcinoma
by: Polina S. Klimovich, et al.
Published: (2021-12-01)

Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).
by: Gerritje J W van der Windt, et al.
Published: (2010-08-01)

Opinion: Methodological Shortcomings in the Study on a Prophage-based PCR Test for Lyme Borreliosis
by: Freek R. van de Schoor, et al.
Published: (2021-12-01)

Salivating for knowledge: potential pharmacological agents in tick saliva.
by: Joppe W R Hovius, et al.
Published: (2008-02-01)

Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis).
by: Kager, L, et al.
Published: (2013)

Bispecific Targeting of EGFR and Urokinase Receptor (uPAR) Using Ligand-Targeted Toxins in Solid Tumors
by: Felix Oh, et al.
Published: (2020-06-01)

Tumour microenvironments induce expression of urokinase plasminogen activator receptor (uPAR) and concomitant activation of gelatinolytic enzymes.
by: Synnøve Magnussen, et al.
Published: (2014-01-01)

Role of CD14 in a mouse model of acute lung inflammation induced by different lipopolysaccharide chemotypes.
by: Adam A Anas, et al.
Published: (2010-01-01)

Redrawing Urokinase Receptor (uPAR) Signaling with Cancer Driver Genes for Exploring Possible Anti-Cancer Targets and Drugs
by: Yu-Ching Chang, et al.
Published: (2023-10-01)

Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.
by: W Joost Wiersinga, et al.
Published: (2010-02-01)

<i>Helicobacter pylori</i> Colonization Drives Urokinase Receptor (uPAR) Expression in Murine Gastric Epithelium During Early Pathogenesis
by: Warner Alpízar-Alpízar, et al.
Published: (2020-07-01)

P25 Leukocyte cell surface expression of urokinase plasminogen activator receptor (uPAR) in patients with systemic lupus erythematosus
by: Christopher Sjöwall, et al.
Published: (2024-03-01)

Mapping the topographic epitope landscape on the urokinase plasminogen activator receptor (uPAR) by surface plasmon resonance and X-ray crystallography
by: Baoyu Zhao, et al.
Published: (2015-12-01)

Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications
by: Niaz Mahmood, et al.
Published: (2018-02-01)

Prognostic Value of Urokinase Plasminogen Activator Receptor (Upar) and Neutrophil CD64 Expression in Acute Respiratory Distress Syndrome Patients
by: H. Hassan, et al.
Published: (2012-08-01)

Vaccination against Bm86 Homologues in Rabbits Does Not Impair Ixodes ricinus Feeding or Oviposition.
by: Jeroen Coumou, et al.
Published: (2014-01-01)

MyD88 dependent signaling contributes to protective host defense against Burkholderia pseudomallei.
by: W Joost Wiersinga, et al.
Published: (2008-01-01)

Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients
by: Louise Madeleine Risør, et al.
Published: (2022-11-01)

Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention
by: Julie Maja Leth, et al.
Published: (2021-08-01)

Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis)
by: Van Der Windt, G, et al.
Published: (2010)

Expression and function of transforming growth factor β in melioidosis.
by: Weehuizen, T, et al.
Published: (2012)

Activation of coagulation with concurrent impairment of anticoagulant mechanisms correlates with a poor outcome in severe melioidosis.
by: Wiersinga, W, et al.
Published: (2008)

A thrombomodulin mutation that impairs active protein C generation is detrimental in severe pneumonia-derived gram-negative sepsis (melioidosis).
by: Liesbeth M Kager, et al.
Published: (2014-04-01)

Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
by: Jan Larmann, et al.
Published: (2015-01-01)

Urokinase-Type Plasminogen Activator Receptor (uPAR) Cooperates with Mutated <i>KRAS</i> in Regulating Cellular Plasticity and Gemcitabine Response in Pancreatic Adenocarcinomas
by: Luogen Peng, et al.
Published: (2023-03-01)

Author Correction: Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients
by: Louise Madeleine Risør, et al.
Published: (2023-01-01)